These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4765907)

  • 1. Studies of incorporation of labelled cyclophosphamide cytembena into human tumour.
    Jandová A; Andrysek O; Macků F; Sámal J; Stránská E
    Neoplasma; 1973; 20(3):297-301. PubMed ID: 4765907
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of incorporation of labelled cyclophosphamide and cytembena into human tumour.
    Jandov A ; Andrysek O; Macků F; Sámal J; Stránská E
    Neoplasma; 1973; 20(3):297-301. PubMed ID: 4725516
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytembena and cyclophosphamide in the treatment of advanced neoplasias of the digestive tract (author's transl)].
    Matĕjková E; Rezábek K; Polák E
    Cesk Gastroenterol Vyz; 1974 Jul; 28(4):279-85. PubMed ID: 4603038
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of inflammatory rheumatic diseases using cytembena].
    Hándlová D; Vojtísek O; Králová M; Brémová A; Kanková D; Pavelka K
    Fysiatr Revmatol Vestn; 1972 Oct; 50(5):278-83. PubMed ID: 4538713
    [No Abstract]   [Full Text] [Related]  

  • 5. [The immunosuppressive effect of Cytembena in rheumatoid arthritis (author's transl)].
    Truhlár P; Matl I
    Cas Lek Cesk; 1975 Jan; 114(5):150-2. PubMed ID: 1120331
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma.
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík F
    Neoplasma; 1971; 18(5):471-2. PubMed ID: 5165867
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of cytostatic activities of cytembena and cyclophosphamide during short-term administration to women with gynaecological carcinoma.
    Skoda V; Jandová A; Novotná J
    Neoplasma; 1970; 17(2):175-81. PubMed ID: 5269150
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experiences with Masterid].
    Heine R
    Med Welt; 1971 Apr; 17():718-20. PubMed ID: 4930464
    [No Abstract]   [Full Text] [Related]  

  • 9. Local effect of Cytembena and Bucky's rays on superficial basaliomas and Bowen's disease.
    Trnka J
    Neoplasma; 1971; 18(5):467-70. PubMed ID: 5119522
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined chemo-radiotherapeutic treatment of breast neoplasms at the metastatis stage].
    Agati G; Stoppa IM
    J Radiol Electrol Med Nucl; 1967 Nov; 48(11):803-4. PubMed ID: 5591688
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of Cytembena in man.
    Grafnetterová J; Schück O; Smahel O; König J; Růzicková S
    Neoplasma; 1971; 18(5):447-54. PubMed ID: 5119517
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumour sensitivity to cytembena in women with metastasizing gynaecological carcinoma in relation to certain inherited blood characters and serum isoenzymes.
    Milunicová A; Jandová A; Skoda V
    Neoplasma; 1971; 18(3):289-98. PubMed ID: 5093948
    [No Abstract]   [Full Text] [Related]  

  • 13. [The possibility of selective chemotherapy of progressive recurring ovarian carcinoma with the aid of cytodiagnosis and incorporation of tagged idoxuridine].
    Dvorák O; Andrýsek O; Stránská E
    Geburtshilfe Frauenheilkd; 1969 Jul; 29(7):648-53. PubMed ID: 5799686
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined chemotherapy in metastatic breast cancer].
    Haab OP
    Praxis; 1967 Jun; 56(25):873-4. PubMed ID: 5632944
    [No Abstract]   [Full Text] [Related]  

  • 15. Qualitative and quantitative changes of nucleoli in lymphocytes of cancer patients during cytembena or cyclophosphamide therapy.
    Matĕjková E; Vlastiborová A
    Neoplasma; 1973 May; 20(5):517-23. PubMed ID: 4800661
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with cytostatic combination therapy in hormone-resistant metastasizing breast cancer].
    Brunner KW
    Schweiz Med Wochenschr; 1969 Sep; 99(36):1298-303. PubMed ID: 5351150
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytembena treatment of advanced gynaecological carcinomas.
    Dvorák O
    Neoplasma; 1971; 18(5):461-4. PubMed ID: 5119520
    [No Abstract]   [Full Text] [Related]  

  • 18. The phase II study: some reflections, particularly concerning disseminated breast cancer.
    Ahmann DL
    Cancer Chemother Rep 3; 1972 May; 3(1):29-32. PubMed ID: 5049705
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of the effects of Cyclophosphamide, Cytembena and Ypenyl in the treatment of inoperable ovarian neoplasms].
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík J
    Cesk Gynekol; 1971 Sep; 36(7):431-3. PubMed ID: 5110665
    [No Abstract]   [Full Text] [Related]  

  • 20. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.